Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F George

Showing results (681-690 of 750) with videos related to

Pageof 75
Sort By:
Journal of Medicinal Chemistry|November 26, 2013
Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4BNanjing Zhang, Xiaoyan Zhang, Jin Zhu, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 23, 2016
2'-Modified Guanosine Analogs for the Treatment of HCVVinay Girijavallabhan, Ashok Arasappan, Frank Bennett, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 10, 2007
Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's diseaseRobert N Baldassano, Jonathan P Bradfield, Dimitri S Monos, et al.
JCI Insight|January 25, 2019
Resident macrophages reprogram toward a developmental state after acute kidney injuryJeremie M Lever, Travis D Hull, Ravindra Boddu, et al.
American Journal of Human Genetics|October 19, 2010
A genome-wide study reveals copy number variants exclusive to childhood obesity casesJoseph T Glessner, Jonathan P Bradfield, Kai Wang, et al.
Bioorganic & Medicinal Chemistry|November 27, 2013
Optimization of potency and pharmacokinetics of tricyclic indole derived inhibitors of HCV NS5B polymerase. Identification of ester prodrugs with improved oral pharmacokineticsSrikanth Venkatraman, Francisco Velazquez, Stephen Gavalas, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2011
II. Novel HCV NS5B polymerase inhibitors: discovery of indole C2 acyl sulfonamidesGopinadhan N Anilkumar, Oleg Selyutin, Stuart B Rosenblum, et al.
The Journal of Allergy and Clinical Immunology|September 2, 2008
ORMDL3 variants associated with asthma susceptibility in North Americans of European ancestryPatrick M A Sleiman, Kiran Annaiah, Marcin Imielinski, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2012
Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitorsFrank Bennett, Hollis S Kezar, Vinay Girijavallabhan, et al.
Frontiers in Immunology|May 31, 2023
<i>Cx3cr1</i> controls kidney resident macrophage heterogeneityAlex Yashchenko, Sarah J Bland, Cheng J Song, et al.
Pageof 75

Showing results (681-690 of 750) with videos related to

Sort By:
Pageof 75
Journal of Medicinal Chemistry|November 26, 2013
Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4BNanjing Zhang, Xiaoyan Zhang, Jin Zhu, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 23, 2016
2'-Modified Guanosine Analogs for the Treatment of HCVVinay Girijavallabhan, Ashok Arasappan, Frank Bennett, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 10, 2007
Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's diseaseRobert N Baldassano, Jonathan P Bradfield, Dimitri S Monos, et al.
JCI Insight|January 25, 2019
Resident macrophages reprogram toward a developmental state after acute kidney injuryJeremie M Lever, Travis D Hull, Ravindra Boddu, et al.
American Journal of Human Genetics|October 19, 2010
A genome-wide study reveals copy number variants exclusive to childhood obesity casesJoseph T Glessner, Jonathan P Bradfield, Kai Wang, et al.
Bioorganic & Medicinal Chemistry|November 27, 2013
Optimization of potency and pharmacokinetics of tricyclic indole derived inhibitors of HCV NS5B polymerase. Identification of ester prodrugs with improved oral pharmacokineticsSrikanth Venkatraman, Francisco Velazquez, Stephen Gavalas, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2011
II. Novel HCV NS5B polymerase inhibitors: discovery of indole C2 acyl sulfonamidesGopinadhan N Anilkumar, Oleg Selyutin, Stuart B Rosenblum, et al.
The Journal of Allergy and Clinical Immunology|September 2, 2008
ORMDL3 variants associated with asthma susceptibility in North Americans of European ancestryPatrick M A Sleiman, Kiran Annaiah, Marcin Imielinski, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2012
Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitorsFrank Bennett, Hollis S Kezar, Vinay Girijavallabhan, et al.
Frontiers in Immunology|May 31, 2023
<i>Cx3cr1</i> controls kidney resident macrophage heterogeneityAlex Yashchenko, Sarah J Bland, Cheng J Song, et al.
Pageof 75